| Induction of high levels of specific humoral and cellular responses to SARS-CoV-2 after the administration of Covid-19 mRNA vaccines requires several days S Gil-Manso, D Carbonell, L López-Fernández, I Miguens, R Alonso, ... Frontiers in immunology 12, 726960, 2021 | 27 | 2021 |
| Comprehensive flow cytometry profiling of the immune system in COVID-19 convalescent individuals S Gil-Manso, I Miguens Blanco, R López-Esteban, D Carbonell, ... Frontiers in immunology 12, 793142, 2022 | 20 | 2022 |
| ABO blood group is involved in the quality of the specific immune response anti-SARS-CoV-2 S Gil-Manso, I Miguens Blanco, B Motyka, A Halpin, R López-Esteban, ... Virulence 13 (1), 30-45, 2022 | 19 | 2022 |
| Multidimensional analysis of immune cells from COVID-19 patients identified cell subsets associated with the severity at hospital admission S Gil-Manso, D Herrero-Quevedo, D Carbonell, M Martínez-Bonet, ... PLoS Pathogens 19 (6), e1011432, 2023 | 10 | 2023 |
| IgG anti-RBD levels during 8-month follow-up post-vaccination with BNT162b2 and mRNA-1273 vaccines in healthcare workers: A one-center study S Gil-Manso, R Alonso, P Catalán, I Sánchez-Arcilla, M Marzola, ... Frontiers in Cellular and Infection Microbiology 12, 1035155, 2022 | 10 | 2022 |
| Ectopic FOXP3 expression in combination with TGF-β1 and IL-2 stimulation generates limited suppressive function in human primary activated thymocytes ex vivo J Gallego-Valle, S Gil-Manso, A Pita, E Bernaldo-de-Quirós, ... Biomedicines 9 (5), 461, 2021 | 9 | 2021 |
| Cellular and humoral responses follow-up for 8 months after vaccination with mRNA-based anti-SARS-CoV-2 vaccines S Gil-Manso, D Carbonell, VA Pérez-Fernández, R López-Esteban, ... Biomedicines 10 (7), 1676, 2022 | 6 | 2022 |
| Evaluation of anti-neuroinflammatory activity of isatin derivatives in activated microglia A Cenalmor, E Pascual, S Gil-Manso, R Correa-Rocha, JR Suárez, ... Molecules 28 (12), 4882, 2023 | 2 | 2023 |
| Neutralizing antibody levels detected early after mRNA-based vaccination do not predict by themselves subsequent breakthrough infections of SARS-CoV-2 R Alonso, S Gil-Manso, P Catalán, I Sánchez-Arcilla, M Marzola, ... Frontiers in Immunology 15, 1341313, 2024 | 1 | 2024 |
| Cellular and Humoral Responses Follow-up for 8 Months after Vaccination with mRNABased Anti-SARS-CoV-2 Vaccines. Biomedicines 2022, 10, 1676. h ps S Gil-Manso, D Carbonell, VA Pérez-Fernández, R López-Esteban, ... doi. org/10.3390/biomedicines10071676, 2022 | 1 | 2022 |
| High specificity of engineered T cells with third generation CAR (CD28-4-1BB-CD3-ζ) based on biotin-bound monomeric streptavidin for potential tumor immunotherapy J Gallego-Valle, VA Pérez-Fernández, J Rosales-Magallares, ... Frontiers in Immunology 15, 1448752, 2024 | | 2024 |
| Caracterización de la inmunidad en pacientes infectados por SARS-CoV-2 y de la respuesta inmune conferida por la vacunación frente a la COVID-19 S Gil Manso Universidad Complutense de Madrid, 2024 | | 2024 |
| AVIDIN-BASED CHIMERIC ANTIGEN RECEPTOR SPECIFICALLY ENHANCES THYMUS-DERIVED REGULATORY T CELLS ACTIVATION AND FUNCTIONALITY J Gallego Valle, V Perez Fernandez, M Martinez-Bonet, R Lopez, ... CYTOTHERAPY 24 (5), S128-S129, 2022 | | 2022 |
| Avidin-based universal CAR regulatory T cells (UniCAR-Tregs): a versatile approach for future immunotherapy J Gallego-Valle, S Gil-Manso, A Pita, E Bernaldo-de-Quiros, ... EUROPEAN JOURNAL OF IMMUNOLOGY 51, 116-116, 2021 | | 2021 |
| Ectopic FOXP3 Expression in Combination with TGF-β1 and IL-2 Stimulation Generates Limited Suppressive Function in Human Primary Activated Thymocytes Ex Vivo. Biomedicines 2021 … J Gallego-Valle, S Gil-Manso, A Pita, E Bernaldo-de-Quirós, ... s Note: MDPI stays neu-tral with regard to jurisdictional claims in …, 2021 | | 2021 |
Marjorie PionHealth Research Institute Gregorio Marañón在 iisgm.com 的电子邮件经过验证
